GALT
Galectin Therapeutics Inc.
Company Overview
| Mkt Cap | $307.49M | Price | $5.87 |
| Volume | 267.23K | Change | +1.03% |
| P/E Ratio | -6.5 | Open | $5.65 |
| Revenue | -- | Prev Close | $5.81 |
| Net Income | $-47.0M | 52W Range | $0.73 - $6.55 |
| Div Yield | N/A | Target | $6.00 |
| Overall | 54 | Value | 40 |
| Quality | 31 | Technical | 91 |
No chart data available
Stock Overview
Updated DailyGalectin Therapeutics Inc. (GALT) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $5.87 with a market capitalization of $307.49 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating concerning quality fundamentals with a MarketXLS quality score of 31.
Today's trading session shows GALT with a volume of 267K shares. The stock opened down 2.75% from yesterday's close of $5.81. Current analyst estimates project earnings of $-0.49 per share for this year, with next year targeting $-0.44.
GALT demonstrates very strong technical momentum based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including MEIP, NBIX, NAVB, NBY.
Key investment considerations for GALT include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 2.2%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 11:17 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GALT | $5.87 | +1.0% | 267.23K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Galectin Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW